Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-up
1. 系统已在2025-06-27 11:42:41对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2352-4642(25)00067-7
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2352464225000677
其他信息:
出版社: Elsevier BV
作者: Han Zhang; Wei Zhao; Xiaoyan Zhang; Lei Zhang; Run Guo; Han Huang; Li Lin; Feng Liu; Haidan Chen; Fangfang Shen; Jinzhun Wu; Xiaowen Huang; Xiaoping Zhu; Feng Li; Gang Zou; Jason Chien; Michael Humphries; Quan Lu; Jim Z Wu; Shunying Zhao; Hanmin Liu; Xin Ni; Cilang Hu; Xueyun Lv; Lili Chen; Shanshan Deng; Kun Jiang; Zhengxiu Luo; Weiling Qiu; Wenhui Jiang; Hongmei Qiao; Yanli Zhang; Jing Liu; Ling Liu; Yanmin Bao; Yiping Chen; Yue Li; Zhaobo Shen; Linan Chen; Hebin Chen; Chuangli Hao
